A diagnosis of uveal melanoma marks the beginning of a long-term relationship with your medical team. While the focus starts ...
(OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 11 December 2024) The European Organisation for Research and Treatment of Cancer (EORTC), an independent clinical cancer research ...
A subgroup analysis of the phase 3 FOCUS study (NCT02678572) shows that the Melphalan/Hepatic Delivery System (HDS; HEPZATO ...
Northwestern Medicine announced Tuesday that for the first time, its doctors have successfully treated metastatic eye cancer using a method that delivers chemotherapy directly to the liver. The ...
The Hepzato Kit is the first FDA-approved liver-directed therapy for unresectable metastatic uveal melanoma, showing consistent efficacy across diverse patient subgroups. Patients with lower tumor ...
ROCKVILLE, Md. and ZURICH, Dec. 9, 2025 /PRNewswire/ -- TrilliumBiO, a leader in biomarker discovery and precision diagnostics, today announced a strategic collaboration with Oncobit, a leading Swiss ...
Servier and IDEAYA Biosciences (IDYA) enter into an exclusive license agreement for regulatory and commercial rights to darovasertib outside the US Darovasertib is a small molecule developed for ...
FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data from a study further ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback